Drugmakers sign on to negotiate Medicare prices under protest
By Michael Erman and Patrick Wingrove (Reuters) - All the drugmakers that make the 10 prescription medicines subject to the first-ever price negotiati...
Stay updated with breaking news from Patrick Wingrove. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Michael Erman and Patrick Wingrove (Reuters) - All the drugmakers that make the 10 prescription medicines subject to the first-ever price negotiati...
A U.S. Patent Office tribunal on Monday rejected challenges to two key patents owned by Novo Nordisk covering the active ingredient in its weight-loss and diabetes drugs Wegovy and Ozempic brought by a generic drugmaker that is hoping to sell generic versions of the blockbuster medications. The office's Patent Trial and Appeal Board denied the requests by Mylan Pharmaceuticals, which is owned by Viatris, to review the validity of the Wegovy and Ozempic patents.
By Michael Erman and Patrick Wingrove (Reuters) - All the drugmakers that make the 10 prescription medicines subject to the first-ever price negotiati...
By Michael Erman and Patrick Wingrove (Reuters) - All the drugmakers that make the 10 prescription medicines subject to the first-ever price negotiati...
By Michael Erman and Patrick Wingrove (Reuters) - All the drugmakers that make the 10 prescription medicines subject to the first-ever price negotiati...